EXPI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EXPI is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some supportive short-term signals, but the overall setup is mixed: price is sitting near resistance, earnings are days away, revenue was slightly down in the latest quarter, and analyst views are sharply divided. If you are unwilling to wait for a better entry, this is still not an attractive immediate buy versus higher-quality long-term opportunities.
EXPI is in a near-term constructive but extended position. MACD histogram is positive and expanding, which supports upside momentum. However, RSI_6 at 69.275 is close to overbought territory, and moving averages are converging, which suggests the trend is not yet a clean breakout trend. Pre-market price at 6.74 is right around resistance at R1 6.753, with the next resistance at 6.918. Support is below at 6.485 and 6.218. In simple terms, the stock is pressing resistance rather than offering a clear discounted entry.
Recent news is clearly positive: eXp World acquired NextHome, which should strengthen market share and brand reach. The company also added experienced agents and commercial talent in recent days, which supports growth and platform expansion. The upcoming Q1 2026 earnings report on May 11 is a near-term event catalyst, and the acquisition could improve investor attention heading into that release. The option market is also leaning bullish.
The latest quarter showed revenue down slightly year over year, which is not ideal for a long-term growth story. Net income remains negative, and EPS is still negative. Analyst opinions are split, with one firm initiating a Buy while another initiated Underperform, showing no clear Wall Street consensus. The stock is also trading near resistance rather than deep value, so the current entry is not especially attractive.
In Q4 2025, EXPI reported revenue of 78.59 million, down 0.35% year over year, indicating flat-to-soft top-line performance. Net income was -12.90 million, though the loss improved 35.68% year over year. EPS was -0.08, also improving 33.33% year over year. This is a mixed quarter: profitability improved, but revenue growth remained weak. For a beginner long-term investor, the business still needs stronger and more consistent growth before it becomes a high-conviction buy.
Analyst sentiment is mixed but slightly improving on the bullish side. Benchmark initiated coverage with a Buy and $8 target, while Zelman initiated with an Underperform and $4.75 target. DA Davidson kept a Buy but reduced its target to $11.50 from $13 due to soft agent trends and weak existing home sales, while still expecting some improvement into the spring selling season. Overall, Wall Street is split: the pros see upside tied to agent count recovery and strategic growth, but skeptics question near-term operating momentum.
